318 research outputs found

    AIFNet: Automatic Vascular Function Estimation for Perfusion Analysis Using Deep Learning

    Full text link
    Perfusion imaging is crucial in acute ischemic stroke for quantifying the salvageable penumbra and irreversibly damaged core lesions. As such, it helps clinicians to decide on the optimal reperfusion treatment. In perfusion CT imaging, deconvolution methods are used to obtain clinically interpretable perfusion parameters that allow identifying brain tissue abnormalities. Deconvolution methods require the selection of two reference vascular functions as inputs to the model: the arterial input function (AIF) and the venous output function, with the AIF as the most critical model input. When manually performed, the vascular function selection is time demanding, suffers from poor reproducibility and is subject to the professionals' experience. This leads to potentially unreliable quantification of the penumbra and core lesions and, hence, might harm the treatment decision process. In this work we automatize the perfusion analysis with AIFNet, a fully automatic and end-to-end trainable deep learning approach for estimating the vascular functions. Unlike previous methods using clustering or segmentation techniques to select vascular voxels, AIFNet is directly optimized at the vascular function estimation, which allows to better recognise the time-curve profiles. Validation on the public ISLES18 stroke database shows that AIFNet reaches inter-rater performance for the vascular function estimation and, subsequently, for the parameter maps and core lesion quantification obtained through deconvolution. We conclude that AIFNet has potential for clinical transfer and could be incorporated in perfusion deconvolution software.Comment: Preprint submitted to Elsevie

    ADL-BSDF: A Deep Learning Framework for Brain Stroke Detection from MRI Scans towards an Automated Clinical Decision Support System

    Get PDF
    Deep learning has emerged to be efficient Artificial Intelligence (AI) phenomena to solve problems in healthcare industry. Particularly Convolutional Neural Network (CNN) models have attracted researchers due to their efficiency in medical image analysis. According to World Health Organization (WHO), rapidly developing cerebral malfunction, brain stroke, is the second leading cause of death across the globe. Brain MRI scans, when analysed quantitatively, play vital role in diagnosis and treatment of stroke. There are many existing methods built on deep learning for stroke diagnosis. However, an automatic, reliable and faster method that not only helps in stroke diagnosis but also demarcate affected regions as part of Clinical Decision Support System (CDSS) is much desired. Towards this objective, we proposed an Automated Deep Learning based Brain Stroke Detection Framework (ADL-BSDF). It does not rely on expertise of healthcare professional in diagnosis and know the extent of damage enabling physician to make quick decisions. The framework is realized by two algorithms proposed. The first algorithm known as CNN-based Deep Learning for Brain Stroke Detection (CNNDL-BSD) focuses on accurate detection of stroke. The second algorithm, Deep Auto encoder for Stroke Severity Detection (DA-SSD), focuses on revealing extent of damage or severity of the stroke. The framework is evaluated against state of the art deep learning models such as EfficientNet, ResNet50 and VGG16

    Artificial Intelligence in the Differential Diagnosis of Cardiomyopathy Phenotypes

    Get PDF
    Artificial intelligence (AI) is rapidly being applied to the medical field, especially in the cardiovascular domain. AI approaches have demonstrated their applicability in the detection, diagnosis, and management of several cardiovascular diseases, enhancing disease stratification and typing. Cardiomyopathies are a leading cause of heart failure and life-threatening ventricular arrhythmias. Identifying the etiologies is fundamental for the management and diagnostic pathway of these heart muscle diseases, requiring the integration of various data, including personal and family history, clinical examination, electrocardiography, and laboratory investigations, as well as multimodality imaging, making the clinical diagnosis challenging. In this scenario, AI has demonstrated its capability to capture subtle connections from a multitude of multiparametric datasets, enabling the discovery of hidden relationships in data and handling more complex tasks than traditional methods. This review aims to present a comprehensive overview of the main concepts related to AI and its subset. Additionally, we review the existing literature on AI-based models in the differential diagnosis of cardiomyopathy phenotypes, and we finally examine the advantages and limitations of these AI approaches

    Efficient Multi-Scale 3D CNN with Fully Connected CRF for Accurate Brain Lesion Segmentation

    Get PDF
    We propose a dual pathway, 11-layers deep, three-dimensional Convolutional Neural Network for the challenging task of brain lesion segmentation. The devised architecture is the result of an in-depth analysis of the limitations of current networks proposed for similar applications. To overcome the computational burden of processing 3D medical scans, we have devised an efficient and effective dense training scheme which joins the processing of adjacent image patches into one pass through the network while automatically adapting to the inherent class imbalance present in the data. Further, we analyze the development of deeper, thus more discriminative 3D CNNs. In order to incorporate both local and larger contextual information, we employ a dual pathway architecture that processes the input images at multiple scales simultaneously. For post-processing of the networks soft segmentation, we use a 3D fully connected Conditional Random Field which effectively removes false positives. Our pipeline is extensively evaluated on three challenging tasks of lesion segmentation in multi-channel MRI patient data with traumatic brain injuries, brain tumors, and ischemic stroke. We improve on the state-of-the-art for all three applications, with top ranking performance on the public benchmarks BRATS 2015 and ISLES 2015. Our method is computationally efficient, which allows its adoption in a variety of research and clinical settings. The source code of our implementation is made publicly available

    Artificial intelligence and cost-effectiveness analyses of radiological imaging in acute ischemic stroke

    Get PDF
    Acute ischemic stroke is caused by an occlusion of an artery in the brain. Current treatment options for acute ischemic stroke are intravenous thrombolysis and endovascular treatment. In this thesis, three parts describe varying analytical approaches to improve acute stroke care. Part I provides model-based health economic analyses of treatment decisions to improve acute stroke care. Specifically, the benefits of expedited endovascular treatment delivery and the use of CT perfusion for patient selection and occlusion detection are described. In Part II, prognostic imaging markers are studied. Deep learning-based quantification of white matter lesion volume in CT is compared to the radiologist-lead Fazekas scale for prognosticating functional outcome and intracranial hemorrhage occurrence. We studied if intravenous thrombolysis before endovascular treatment might be withheld based on increased risks for poor outcome and intracranial hemorrhage related to white matter lesion load. Furthermore, we evaluated thrombus volume, thrombus length, and thrombus radiomics as patient functional and endovascular treatment procedural outcome predictors. In Part III, we used generative adversarial networks to perform image-to-image translation. We translated CT scans with follow-up hemorrhagic or ischemic stroke lesions to baseline CT scans without. Furthermore, we remove contrast in CTA by translating a CTA to a non-contrast CT. Based on these translations we extract lesion segmentations in follow-up CT and vessel segmentations in CTA

    Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation

    Get PDF
    We propose a dual pathway, 11-layers deep, three-dimensional Convolutional Neural Network for the challenging task of brain lesion segmentation. The devised architecture is the result of an in-depth analysis of the limitations of current networks proposed for similar applications. To overcome the computational burden of processing 3D medical scans, we have devised an efficient and effective dense training scheme which joins the processing of adjacent image patches into one pass through the network while automatically adapting to the inherent class imbalance present in the data. Further, we analyze the development of deeper, thus more discriminative 3D CNNs. In order to incorporate both local and larger contextual information, we employ a dual pathway architecture that processes the input images at multiple scales simultaneously. For post-processing of the network's soft segmentation, we use a 3D fully connected Conditional Random Field which effectively removes false positives. Our pipeline is extensively evaluated on three challenging tasks of lesion segmentation in multi-channel MRI patient data with traumatic brain injuries, brain tumours, and ischemic stroke. We improve on the state-of-the-art for all three applications, with top ranking performance on the public benchmarks BRATS 2015 and ISLES 2015. Our method is computationally efficient, which allows its adoption in a variety of research and clinical settings. The source code of our implementation is made publicly available.This work is supported by the EPSRC First Grant scheme (grant ref no. EP/N023668/1) and partially funded under the 7th Framework Programme by the European Commission (TBIcare: http: //www.tbicare.eu/ ; CENTER-TBI: https://www.center-tbi.eu/). This work was further supported by a Medical Research Council (UK) Program Grant (Acute brain injury: heterogeneity of mechanisms, therapeutic targets and outcome effects [G9439390 ID 65883]), the UK National Institute of Health Research Biomedical Research Centre at Cambridge and Technology Platform funding provided by the UK Department of Health. KK is supported by the Imperial College London PhD Scholarship Programme. VFJN is supported by a Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship. DKM is supported by an NIHR Senior Investigator Award. We gratefully acknowledge the support of NVIDIA Corporation with the donation of two Titan X GPUs for our research
    corecore